APA (7th ed.) Citation

Rezaee, M., Ravangard, R., Mojtabaeian, S. M., & Jafari, A. (2024). Cost-effectiveness of oral versus injectable disease modifying therapies in relapsing multiple sclerosis: A systematic review analysis. BMC Health Services Research, 24(1), 1. https://doi.org/10.1186/s12913-024-11800-8

Chicago Style (17th ed.) Citation

Rezaee, Mehdi, Ramin Ravangard, Seyyed Morteza Mojtabaeian, and Abdosaleh Jafari. "Cost-effectiveness of Oral Versus Injectable Disease Modifying Therapies in Relapsing Multiple Sclerosis: A Systematic Review Analysis." BMC Health Services Research 24, no. 1 (2024): 1. https://doi.org/10.1186/s12913-024-11800-8.

MLA (9th ed.) Citation

Rezaee, Mehdi, et al. "Cost-effectiveness of Oral Versus Injectable Disease Modifying Therapies in Relapsing Multiple Sclerosis: A Systematic Review Analysis." BMC Health Services Research, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12913-024-11800-8.